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1. Introduction 
1.1 Transition of care 
Chronic rheumatic diseases in childhood are an important group of chronic conditions with 
often severe morbidity and carrying a major impact on growth and development for the 
affected individual. It is estimated that 30-70% of the patients have continuing disease 
activity or persisting limitations in functional ability or psychosocial function in their adult 
life (1-4).  
In most countries infants and children with rheumatic diseases are treated by specialist 
pediatric rheumatologists, nurses and physiotherapists. When such children with chronic 
diseases reach adulthood (usually between the age of 16 -24), transition to adult health care 
is needed. This transitional face coincides with the period in which adolescence, or puberty, 
takes place. Blum and colleagues coined a very useful definition for transition (5). They 
described transition as ‘the purposeful, planned movement of adolescents and young adults 
with chronic physical and medical conditions from child-centered to adult-oriented health 
care systems’  
The transfer to adult health service requires specific skills and knowledge from the health 
care providers. When ignored this may result in poor health indicators and loss to follow-up 
for adolescents with a chronic disease. Basically one needs to recognize that children with 
severe chronic diseases transgress into a two faced transition to become an adolescent with a 
chronic rheumatic condition that receives care from a team expert in both pediatric and 
adult rheumatology. Nowadays, it is generally believed that a multidimensional transition 
of care is needed (6;7).   
In the US a general statement was made by pediatricians and primary health care that 
transition leading to the transfer of care is one of six primary goals for youth with special 
healthcare needs {25} 
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Apart from these issues, other questions to be discussed in this chapter are: 
 What is the right time for this transfer of care and who plays a role in this process? 
 Which aspects of adolescence play a role in the transfer and transition of care? 
 What special preparations are needed for this transfer? 
 What does an ideal transition of care system look like? 
Most published descriptions of the organization of transition of care for rheumatic diseases 
refer specifically to Juvenile Idiopathic Arthritis (JIA). Therefore this chapter will also focus 
on JIA. For the other rheumatic diseases the JIA centered transition programme may serve 
usefull. However in such cases (for instance SLE, juvenile dermatomyositis, 
autoinflammatory syndromes) the team also needs to include renal and dermatological 
expertise.  
2. Factors influencing the transfer from pediatric to adult care 
2.1 Differences in culture of medical treatment and care in pediatrics and adult 
medicine 
In pediatric medicine, health care should not be limited to the patient’s disease. Other 
aspects of physical development should be taken into account such as growth and puberty. 
Education and social behavior in the presence of a chronic disease are equally important 
issues, not only for social development, but also for future opportunities in finding 
employment. Sport and exercise are important for maintaining social contacts as well as 
mental and physical health. Furthermore, parents and siblings are also involved in the 
disease process of the diseased child. Limitations caused by the disease may have an effect 
on the social life of the whole family.  
In adult medicine much attention is given to the rheumatic disease itself, the disease activity 
and side effects of medications. The impact of the disease on work, family and social life is 
less important and is hardly discussed by the medical doctor. When supporting staff like 
nurse practitioners, social workers or physiotherapists are available, these factors are taken 
into account, which certainly play an important part on issues such as staying in 
employment, self efficacy, compliance etc. The care for the patient is often structured in a 
supply-oriented fashion and can be divided into the available separate disciplines. (8;9).  If 
transition programmes are fully patient-oriented they will offer a merge of paediatric and 
adult care. 
 
Pediatric care Adult Care  
Family-focused (parents strongly 
involved) 
Patient-focused 
Generalist, interdisciplinary Multidisciplinairy 
Socially orientated Disease orientated 
Informal atmosphere, relaxed Formal atmosphere, to the point 
Attention for development, school and 
social functioning 
Accent on treatment, self-management and 
compliance 
Table 1. Differences in pediatric and adult care (8;9)  
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2.2 Who is involved in the transition process?   
First and foremost of course, is the adolescent suffering from the chronic (rheumatic) 
disease, the patient who is transferred to adult care.  
Secondly, the paediatric specialist, the person who is responsible for  handing over a 
complete medical file of the patient. The paediatric specialist is usually assisted by allied 
health professionals such as specialised physical therapists, psychologists and social 
workers. In addition, the paediatric services together with the adult services are involved in 
preparing the patient and the parents for the new situation at adult health care. 
The adult specialist needs to be prepared for looking after a young patient in adolescent age 
with a long medical history. Often the disease has already caused irreversible damage and 
influences growth and development, as well as functional and social performance. One 
needs to realise that the pattern of joint erosions are often different from adults with RA and 
that the uveitis so commonly seen in JIA is rare in RA. For young patients visiting the adult 
department with a relative short disease duration, without such effects of longstanding 
disease this is of course different. Also, the adult specialist needs to deal with a patient in the 
adolescence phase. Often the disease has had influence on growth and development, and 
functional and social outcome. This, however, is different for young patients attending the 
adult department who had a relatively short disease duration, and who haven’t displayed 
the effects of a longstanding disease.  
Finally, the parents and extended family who have been involved in the disease process for 
a long time as they have had to take care of the medication and appointments at the hospital 
and sometimes needed to give extra support in nursing their child. When growing up, the 
child needs less support. The parent is required to release the responsibilities and hand 
them over to their child. At the adult department all responsibilities must be taken on by the 
patient themselves. This requires a self confident, considerate and often independent person 
that is capable to self-manage all aspects of the disease. 
3. Aspects of transition 
3.1 The concept of self-management 
This is described as the transition of the patient from a dependant (childhood) state into a 
self caring adult person.    
As the young child grows up into adulthood via adolescence it will develop a set of tools to 
cope with this new situation. Such a transition into adulthood (defined by Hardoff (10)) is a 
period of biological, social and emotional change, in which the adolescent has 4 major tasks: 
 to consolidate their identity;  
 to achieve independence from their parents;  
 to establish adult relationships outside the family;  
 to find a vocation. 
The adolescent with a chronic disease, however, has additional tasks:  
 they have to cope with the disease; 
 the treatment and its functional limitations; 
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 they have to learn to do that independently from the support team which was available 
to them in their childhood, e.g. the parents and pediatric health services. 
Hence, it is not surprising that the value of self-management interventions that train 
patients to utilize relevant skills is the subject of increased attention (11), see ref White 
articles [5]. Self-management may be one means of bridging the gap between patients’ needs 
and the capacity of health and social care services to meet those needs. 
Self-management is generally held as one of the key elements in a transition program.  
But other skills are also important like communication, decision making and assertiveness 
(12-14). Patients in the adolescent ages were interviewed by Stinson et al (13) about their 
strategies of gaining control over managing their illness on their own. The two strategies 
that assisted the process of transition were:  
 gaining knowledge and skills to manage the disease and;  
 experiencing understanding through social support.  
The authors concluded that web-based interventions could be a promising tool in 
supporting the acquisition of knowledge (13). 
Table 2 summarizes the knowledge and skills needed for transition of the adolescent. These 
items can be prepared by the pediatric and adult health department workers including the 
specialist, but also parents and peers (healthy as well as those with a chronic disease) are 
important (12;15).  
I: Knowledge for transition 
Condition including effects on body, medical history and prognosis 
Therapy regimen including names, doses, side effects, rationale,  
risk of non-adherence 
Purposes of tests and procedures 
Relevant medical terminology 
Specific issues, e.g., antibiotic prophylaxis, immunizations 
Role of health care providers, what they do, and how to access their services 
Meaning of transition 
Differences between pediatric and adult health care 
Healthy lifestyles in terms of exercise, nutrition, sun exposure etc 
Impact of drugs and alcohol on condition and therapy 
Impact of condition and therapy on sexual and reproductive health 
Impact of condition and therapy on education and vocation  
II: Skills for transition 
Health:  
Feeling confident to see health professional independent of parents 
Accessing health care independently, including booking appointments, seeking advice 
and refilling prescriptions 
Self management of their condition 
Adherence to  therapy and appointments 
Pain and fatigue management skills 
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Psychosocial:  
Independent living skills, self care, meal preparation, hobbies 
Peer support including independent social life and social competencies 
Educational/ vocational: 
Communication skills 
Vocational education, work experiences, (part-time) jobs 
Table 2. Knowledge and skills needed for transition (12, 15): 
Recently several internet based programs for increasing self-management have been 
developed (16;17). 
Interestingly, in a recent survey in our outpatient population of 142 adolescents (age 10-27 
years) with JIA , internet is widely used (97.9% of the patients had access to internet) and 77% 
were daily on the internet. However, only 26% surfed for information about their disease.  
The time to start the self-efficacy process with gaining knowledge about disease and related 
issues should be as young as possible. This will help them to cope with their disease later on 
in life, its limitations and the opportunities that arise, for instance in finding suitable 
employment, social activities they can partake in, the importance of taking their medication 
and monitoring their own health including making own appointments and  independently 
visiting the clinic (15). Data from a UK study supported an early start to transition, whereby 
11-14 year-old patients with JIA showing maximum improvement in disease knowledge 
after 12 months of participation in a transitional care program, which was significantly 
higher than that of a 17-year-old patient at baseline (18).  
3.2 Documentation of disease activity of JIA patients 
Despite its name juvenile, JIA is not a disease in childhood only, it may persist into 
adulthood. In retrospective and cross sectional studies which have been published, complete 
remission after at least 10 years of disease duration is described in 33-67% of the patients, 
depending on JIA subtype, and patient population (2;4;19-22). The prognosis is better in the 
oligoarticular persistent subtype and worse in the systemic group.  
Due to higher rates of remission, it is expected that patients with the oligoarticular persistent 
subtype are lost to follow up. A selection bias of patients after longer disease duration is 
therefore to be expected. Results of the disease activity of patients with very long disease 
duration should therefore be analyzed with care as most of the long-term outcome studies 
of patients with JIA are retrospective and cross-sectional.  
Further in this chapter we will highlight the aspect of the tools used to measure disease 
activity. 
3.3 Medication history 
Prognosis in RA has improved enormously these last years since intensive combination 
treatment regimes have been introduced (23). Complete remission is now noted, low DAS 
scores or other activity scores are commonly used to control disease activity (24;25). Only 
very recently remission criteria for RA are defined, but studies using these criteria are not 
published yet (26). 
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Similar to adults, treatment for JIA has improved dramatically in the past 20 years. Outcome 
of older patients is therefore hard to compare with younger patients. Patients are treated 
differently over time and between centers. Before the introduction of MTX and  SASP in the 
1990’s patients were treated with aspirin and corticosteroids.  
From the 1990’s on the pyramid was dismantled (27). The introduction of DMARDs like 
MTX and SASP changed prognosis (28;29) (30;31) 
Another true revolution was the use of “biologicals” in JIA. Instead of controlling the 
disease nowadays physicians aim at curing the disease. Especially the follow up of the 
group of JIA patients in remission without medication, as defined by Wallace (32) will show 
us in due time whether this is indeed possible. 
Following the initial description of the effects of etanercept in adult patients with RA, the 
first study in children treated with etanercept was described in 2000 by Lovell et al (33). 
Other biological therapies for children were described in later years. Biological treatment 
like adalimumab and abatacept, first used successfully in adults with RA are now 
prescribed to younger patients with JIA. Other biologic agents were not studied in a way 
that enabled FDA or EMA registration and such drugs are thus still used off label in 
children. 
3.4 Compliance 
Compliance is generally defined as a patient's adherence to a recommended course of 
treatment. Other words used are agreement, conformity, cooperation, respect, submission. 
Agreement, conformity are difficult terms for adolescents, as they are searching for methods 
to become independent from the usual carers (parents, but indeed sometimes also the 
doctor). It is not surprising that compliance in this patient group on their way to 
independence can be low.  
Corticosteroids with known side-effects as a moonface and disfiguring striae have low 
compliance rates. The combination of alcohol and MTX is not advised, which in turn, can 
cause delay in therapy. Compliance can be a huge problem in severe, probably life 
threatening systemic diseases like SLE or systemic JIA.  
In the long term, compliance may have an influence on the outcome of JIA patients. As 
adolescents have a low compliance rate in visiting their doctor, their patient data are lost in 
the follow-up phase. Changing schools or finding a job sometimes also causes a migration, 
similarly, when disease activity is quite low, the patients don’t make new appointments.  
Exact figures are therefore not known.    
Kroll described the factors that comprise treatment adherence. In his view, the facilitating 
strategies are child-centered information, therapy management, behavior modification and 
parental monitoring (34). Modern techniques can be helpful in improving compliance like 
internet-based self management programs with telephone support (17) or electronically 
monitored adherence to medication(35). 
Increasing compliance can be supported by parents and other (health) carers. 
Notwithstanding the above , the main advice for the parent is to “let the patient go”.  
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3.5 Education 
Several studies have been done to evaluate educational and occupational outcome of young 
adults with JIA. Results are conflicting in different countries. 
In the USA (36) educational and occupational outcome after a median disease duration of 
12.6 years, were similar to adult peers. In Canada, educational level was lower for female 
patients and unemployment rates were higher(20). 
In the UK, Foster et al and Packham et al evaluated in different studies educational 
attainment and employment status. They concluded excellent educational attainment but a 
high rate of unemployment among the patients (37;38).  
In Germany, also educational achievements of patients were higher but rate of 
unemployment was lower compared with the age-matched population (4).  
The long-term outcome studies evaluated all JIA subtypes, although median disease 
duration was longer in the UK studies (12.6 years versus 21 and 28 years). Whether lower 
functional outcome plays a role in unemployment ratio is not known as this is not 
investigated in all studies. 
In some countries more support is given to persons with disabilities. It may be that JIA 
patients receive sickness or disability benefit and are therefore not included in 
unemployment figures. 
3.6 Psychological aspects  
Psychological and social aspects as well as coping strategies are well documented in 
younger children with JIA (39;40).  
Only a few long term outcome studies in adolescents and adults with juvenile arthritis have 
been published. Significantly impaired physical health but no psychosocial health 
differences were found compared to the general (Norwegian) population(41). Patients with 
significant disabilities (Steinbrocker class III or IV) (42) or longstanding disease activity (43), 
show psychological distress in about one-third of the cases.  
Despite reported psychological problems only few patients show social adjustment 
problems (4;19)). Overall, the literature on psychological outcome has shown contradictory 
conclusions. This may be due to  variations of  the measures used, time since onset of 
disease, inclusion or omissions of controls, the study design, and disease severity or degree 
of disability. The age seems  particularly important because psychosocial adjustment may 
change as patients pass through life’s developmental stages(44). 
3.7 Long term outcome of JIA 
In longterm follow up studies approximately half of the patients have active disease and/or 
changes in body structures to a variable extent. Approximately one-third of the patients 
rated themselves as being functionally limited (3). Little is known about long-term effects of 
medication, especially the more recently introduced DMARD’s and biologicals.  
Complete remission in JIA is achieved in 33-67% of the patients, depending on the subtype.  
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In JIA remission criteria are defined by Wallace et al (32). One of the main differences with 
adult health care is that complete remission in JIA is defined as “no disease activity”, no 
active joints and low sedimentation rate and or CRP with low physician’s global assessment. 
In adult health care remission used to be defined by low DAS scores but some disease 
activity may persist. 
Remission per subtype JIA 
- Systemic     47-76% 
- Oligo persistent/extended    35-57% 
- Polyarticular RF+   0-15% 
- Polyarticular RF –   30-46% 
- Enthesitis related   18% 
- Psoriatic     33% 
(2;4;19;20). 
In the past few years, the prognosis for RA has improved enormously since the introduction 
of intensive combination treatment regimes (23). Complete remission has not been noted, 
low DAS scores or other activity scores are commonly used to judge disease activity (24;25). 
However, for instance for patients with JIA the aim of the pediatrician is to reach complete 
remission of the disease. This is in sharp contrast to the generally accepted disease activity 
within adult rheumatology. Until very recently, in adult RA new remission criteria have 
been defined, although new studies using these criteria have not been published yet (26). 
The long term complications of JIA and RA are different. Adequate control of inflammation 
has made Felty syndrome and amyloidosis nowadays very rare complications in JIA, 
whereas it occurs in 1.4% of adults with RA. In RA, residing functional disability is higher 
(HAQ >0: is seen in 36% - 72% of patients), as are erosions and other radiological changes 
like growth deformities, fusion, osteopenia (seen in 25%- 68%).(2;3;19;21;45).  
3.8 Developmental aspects  
Research has been carried out on the impact of JIA later on in the life of its patients, and 
important differences between healthy adolescents and young adults suffering from JIA 
have been found.  
For instance in studies done in Europe one of the aspects is the growth difference in JIA 
patients. In Germany, girls final height is 2 cm shorter than their peers, for boys this is 1 cm 
(46). In Great Britain, the final height differential is much larger, 4 cm in girls and  4 cm in 
boys, compared to their peers (47). In the Netherlands, a study is ongoing on the 
developmental aspects of adolescents with JIA. We found 2 cm decrease in the final height 
of girls, and only 0,5 cm for boys. Research on growth differences in the United States or 
South America hasn’t been carried out yet. 
Growth and final height depends on several aspects. 
Malnutrition is common among patients with a chronic disease. Further influence on final 
height are the age at which the puberty starts, and the clinical progression of puberty and 
growth spurt (48;49). Possibly abnormalities in the growth hormone axis plays a role (49-51). 
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A number of (retrospective) studies have been carried out amongst adult women with JIA 
and the potential influence of JIA on sexuality and fertility and indirectly, on their number 
of children. No randomized controlled trials are known, all data were retrospectively 
collected. Conclusions of the authors were that the number of successful pregnancies is 
comparable to healthy controls, although in our observation this conclusion may be too 
hasty. The number of miscarriages was not mentioned in any (retrospective) studies, and 
also fecundity (time to conceive) was not taken into account. More research needs to be done 
in adult patients (1;52;53). 
3.9 Transfer of a complicated medical history      
Failure to coordinate care between providers of the pediatric and adult health system 
adversely affects both quality and efficiency of care. Planning, information and warnings to 
the next care provider are very important. Documentation of relevant information is 
important in view of the multidisciplinary nature of transitional care. One can imagine the 
results of prescribing wrong dosage of for example MTX or TNF blockers on internal organs. 
Also when medication history is insufficient (eg not mentioning cyclofosfamide) severe 
physical problems are to be expected. 
In a study carried out in the UK it was shown that detailed and extensive documentation 
significantly improved following participation in a transitional care research program 
(15). 
Nowadays with the support of electronic patient files these problems should be of the past, 
but these modern techniques are not widely available yet. A summary of medical history 
and used medication on the past and current medical problems can overcome this problem. 
Social and psychological issues must also be explained and transferred to social workers 
within the adult department.  
3.10 Transfer of knowledge from pediatrician to adult physician     
In 2002, a consensus document on transition of care was approved by the American 
Academy of Pediatrics, The American Academy of Family Physicians, and the American 
College of Physicians-American Society of Internal Medicine (54).  This consensus statement 
states that all young people with special health care needs such as rheumatic diseases 
should have the following: a professional with the appropriate transition care knowledge 
and skills who attends to the unique challenges of health care transition; a written health 
care transition plan by the age of 14 including a constantly updated medical summary that 
is portable and accessible to the youth and family; care guided by the primary and 
preventive care guidelines for al adolescence and young adults; and affordable, continuous 
health coverage.  
Unfortunately, in 2005, a survey done in Pennsylvania, USA, to evaluate the consensus 
statement in practice, revealed that 57% of the practices had not started any of the transition 
guidelines (55).  
Also outside the US, the availability of appropriately trained staff and in-service training to 
maintain staff members’ skills and knowledge in adolescence is considered important. In a 
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Delphi study done in the UK, availability of professionals who were knowledgeable in 
transitional care was reported to be best practice (56). 
However, well trained staff in knowledge of adolescence is rare. 
McDonagh described the unmet skills and training needs in health professionals dealing in 
adolescence. In the below many subjects are mentioned. 
 
 Perceived 
skill/comfort 
level (Very 
low/low)  
n (%)  
Perceived knowledge of 
available 
information/resources 
(Very low/low)  
n (%)  
Perceived importance of 
issue being addressed in a 
rheumatology clinic 
(moderate/high/very 
high)  
N (%) 
Suicide risk 15 (68) 13 (59) 19 (86) 
STDs/HIV/hepatitis 12 (54) 7 (33) 17 (77) 
Gay/lesbian sexuality* 11 (52) 16 (76) 13 (59) 
Drug use 10 (45) 13 (59) 20 (91) 
Eating disorders 9 (41) 11 (52) 20 (91) 
Physical/sexual abuse 9 (41) 6 (27) 20 (91) 
Dating/vulnerability 9 (41) 17 (77) 17 (77) 
Vocation/employment 7 (32) 9 (41) 20 (91) 
Contraception/safe 
sex 
6 (27) 8 (36) 19 (86) 
Parental conflict 5 (23) 12 (55) 18 (82) 
Driving 5 (23) 9 (41) 18 (82) 
Alcohol use 4 (18) 9 (41) 21 (95) 
Smoking 4 (18) 7 (32) 20 (91) 
Body image* 3 (14) 15 (68) 21 (95) 
Peer relations 3 (14) 12 (55) 19 (86) 
Nutrition 3 (14) 3 (14) 21 (95) 
Depression/anxiety 2 (9) 8 (36) 21 (95) 
Psychosomatic 
complaint 
2 (9) 4 (18) 20 (91) 
Education* 2 (9) 5 (23) 19 (86) 
Exercise 0 (0) 0 (0) 20 (91) 
Table 3. (57) Respondents’ perceived skill/comfort level in dealing with adolescent issues, 
their perceived knowledge of resources and their importance in a rheumatology clinic  
(n = 22)  
4. Adaptations from pediatric to adult health care   
JIA is a heterogeneous group of 7 diseases, comprising from systemic JIA, oligo-articular 
and poly-articular JIA, enthesitis related JIA (also called juvenile spondylarthropathy), 
psoriatic arthritis and undifferentiated JIA (58). Only the extended oligo-articular JIA and 
poly-articular JIA can fit in the diagnosis RA with regards to disease symptoms.  
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The definition of Rheumatoid Arthritis used to be strict, (ACR criteria 1987), but recently this 
definition is considered to be imprecise, since also early arthritis with relative short disease 
duration is treated as RA. However, the term is generally used to describe a symmetrical, 
persistent, and destructive poly-arthritis often associated with a  rheumatoid factor or with 
positive results in tests for anti-cyclic citrullinated peptide (anti-CCP) antibodies (59).  
4.1 Different scoring methods 
Most studies describing long term outcome of JIA patients use adult outcome parameters to 
show for example disease activity, functional outcome or psychosocial outcome ((1;3;20).  
But are  those the right tools to compare  the disease activity in each individual patient from 
the start of their disease into their adult life? Or even, can we use these parameters to 
compare RA patients with JIA?  
Pediatric multicenter trials have developed a uniformly accepted way of measuring disease 
activity (60). The initial ACR scores for children (Ped-ACR 30-50-70-90) were adapted from 
the adult scores (ACR 30-50-70 and 90%). It should be noted however that these ACR/Printo 
scores were specifically designed for measuring change induced by medication. More recent 
tools such as JADAS include a single point total score similar to the adult DAS instead of 
measuring the percentage of change to baseline values.  Most used variations in adults with 
RA are DAS 28 and DAS 44 (61;62). In pediatric rheumatology in 2009 the Juvenile DAS is 
introduced, variations are the JADAS 10, 27 and 71. The Correlations between the 3 JADAS 
versions was comparable, but better than the DAS 28 and the CDAI (Clinical Disease 
Activity Index).  
Functional outcome at pediatric age is measured by the Childhood Health Assessment 
Questionnaire, a derivative from the Health Assessment Questionnaire, which is used for 
adults. We have compared both questionnaires and used the same adolescents and young 
adults with JIA. Despite strong correlations in consistency, and independent of age, we 
found a lack of agreement for the outcome of CHAQ and HAQ (63).  This implies that the 
functional outcome as measured by the CHAQ is not directly comparable to the HAQ when 
measured at the same time. Direct matching is therefore not possible. Further research in 
follow-up data is ongoing. When following the patient at an adult age for a longer period, as 
will be done in transition phase, outcome parameters will have to be comparable to those 
measured at pediatric age. 
A multidimensional assessment questionnaire was proposed including physical, 
psychosocial and compliance aspects (JAMAR) (64). The JAMAR includes 15 parent or 
patient-centered measurements or items that assess well-being, pain, functional status, 
health-related quality of life, morning stiffness, disease activity, disease status and course, 
joint disease, extra-articular symptoms, side effects of medications, therapeutic compliance, 
and satisfaction with illness outcome. The JAMAR is proposed for use as both a proxy-
report and a patient self-assessment report, with the suggested age range of 7-18 years for 
use as a self-assessment report. However even this multidimensional score does not 
measure in detail the consequence of certain limitations for participation in daily life 
activities. The full impact of certain limitations can only be learned from our patients.  
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4.2 Models for transition of care 
Transition of care for the adolescent with a chronic disease is complex. Many people are 
involved, the patient, his or her parents, the pediatrician and the adult specialist. Often also 
other co-workers like social workers or physiotherapists are involved. Therefore a number 
of health service models have been proposed, including the patient-focussed model, a 
disease-focussed model, hospital-based model, a team-based outside the health service, a 
named person, a voluntary organisation and a primary care model (65).  
For patients with rheumatic diseases 3 units have described their programs in literature (66-
68), all disease focussed models.  
While et al developed the disease focussed model of transition further and described 4 
models (table) 
 
Models of transition for evaluation 
Direct transition (communication and information sharing only) 
Sequential transition (includes the development of new services like adolescent clinics) 
Developmental transition (includes skill training and support system development) 
Professional transition (transfer of expertise only) 
Table 4. (11) 
When summarizing the most important needs for transition the following key components 
for the organisation of care can be  noted (12):  
 Future focused, patient-centered 
 Inclusive for parents/ caregivers 
 Early start (11-14 years) 
 Multidisciplinary, paediatric and adult services, social workers, education 
 Dynamic and flexible process in a resilience framework (ITP, Individual Transitional 
Plan) 
 Coordinated, uninterrupted health care 
 Age and developmentally appropriated 
 Skills training for the young person in communication, decision making, 
assertiveness, self-management 
5. Complications in transition of care 
5.1 Complications for the patient      
Complications of transition have been well described(6). During transition a whole list of 
topics needs to be discussed with the adolescent and this is usually the cause of such 
complications. Some of these topics are for example self care and communication skills: 
medication is not prescribed because the patient doesn’t ask for a recipe; the patient gets 
pregnant while taking MTX because contraceptives haven’t been discussed. 
McDonagh suggested a list of topics to be discussed during transition of care are(6):  
 decision making  
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 independent visits 
 phoning with own queries 
 communication skills 
 self care including compliance 
 level of parental concern 
It is suggested that quality of medical care for young people with chronic disease 
deteriorates after transfer to adult services has taken place (69). 
Potential explanations of deteriorating quality of medical care could be due to: 
- reduced therapy goals (low disease activity instead of remission) 
- reduced compliance of the adolescent 
- insufficient transfer of care by the pediatric and adult health services 
A complication in insufficient transfer of medical care of the adolescent with a rheumatic 
disease can be that the patient is lost in the medical system and not returning to a medical 
clinic for rheumatic diseases (either returning back to the pediatrician or visiting a different 
adult department). 
It is not clear how many patients are lost in their follow up after their transition to adult 
health care. Even in large outcome studies of adult patients with JIA exact numbers can not 
be determined (2-4). 
There are numerous reasons why these patients are missing from the medical system after 
their transfer to adult health care: 
- Their disease may be in remission 
- They may have moved or even migrated abroad  
- There is insufficient availability of (adequate) rheumatologists 
- There is insufficient preparation for adult health care (failure of transition of care 
process) 
- Non compliance of the patient:  
Too busy with study, new home, new friends or new job to visit a rheumatologist 
Loss of confidence in adult care 
No interest in own health 
Incapacity to deal with independent self-care 
Apart from the risk of no-shows, there are potential problems that the patient finds it 
difficult to cope with such as: 
- their persistent disease activity to which insufficient attention is given 
- their reduced functional ability whereby no additional help is offered 
- the side effects of their medication 
- psychological symptoms like depression 
- insufficient self care, ongoing dependency on parents or partner 
In pediatric health care, the medical approach is from a multi-disciplinary perspective 
whereby the patient’s whole well-being is taking into account.  
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5.2 Complications for the carers   
Most adult rheumatologists are not trained in adolescent medicine and the subjects 
associated with adolescence and their subsequent handling of the rheumatic disease. Also 
some professionals may simply not like looking after adolescents and find their non-
compliance and uncommunicative behaviors an irritation in an adult clinic (6). 
The adolescent patient (as any other healthy person of this age range) requires special 
attention as he or she is in a period of transition from a dependant to an independent state. 
At adolescence the child’s focus shifts away from family to peers. This important move 
should be no different for chronically ill adolescents. Adolescents begin to adopt a multitude 
of new social and emotional roles and learn to cope with altered bodily functions. 
Adolescents with a chronic disease are constantly struggling with independence. At the 
same time, their illness often keeps them tied physically, emotionally and financially to their 
families. 
Moreover, a chronic disease like JIA or its treatment may interfere with the normal growth 
process like muscle strength and sexual maturity (70).  
Factors which play a role during normal adolescence are 
 Independence and assertiveness 
 Peer relationships 
 School at work 
 Physical appearance 
 Sexuality 
 Death and dying 
Besides culture differences, adult rheumatology services are frequently different from 
pediatric rheumatology services in the following aspects(6): 
- Time available for consultation 
- Continuity of care in terms of the same doctor at consecutive visits 
- Format of referrals to allied professionals, usually by short paper referrals rather than 
detailed in person overview during a meeting of the rheumatology team. 
When these issues are not taken into account during the transition phase transfer, problems 
are expected.  
6. Future developments 
6.1 Optimal organization of transition of care   
Papers and textbooks dealing with transition of care often provide interesting descriptions, 
theories and hypothesis rather than solid empirical data. The importance of a transition 
program for adolescents with JIA is widely recognized but the lack of solid data from 
studies to base the policy on is remarkable. Just very few studies have been published with 
data to support current programs (14). Most published studies evaluating transitional care 
have been for patients with diabetes mellitus, with programs targeted at improving patient 
education, staff continuity or delivery of service. 
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This existing evidence supports the use of educational programs, joint pediatric and adult 
clinics and specific young adult clinics. Evidence for patients with rheumatic disease 
however have not been published yet, most likely because outcome markers for these 
chronic diseases are rather complex, while in diabetes disease specific biochemical 
indicators like HbA1c are used.  
When summarizing the most important needs for transition in rheumatology, the following 
key components can be distinguished(7;12;71):  
 Medical care in the transition phase should be focused on the future of the adolescent 
patient, and centred around the young adult 
 Health care should include parents as well as support health staff 
 Start of the transitional process should be addressed at the start of the adolescence (11 – 
14 years)  
 The medical approach should be from a multidisciplinary perspective, and include both 
paediatric and adult services, as well as social workers and educational experts 
 It should be a dynamic and flexible process in a resilient framework (ITP, Individual 
Transitional Plan)  
 Coordinated, uninterrupted health care 
 Appropriate for age and developmental stage 
 Include skills training for the young person in communication, decision making, 
assertiveness, self-management(72) 
 Make plans for the future (peer support including independent social life and 
social competencies, education, housing)  
 Policy regarding contact after transfer to adult services 
 Evaluation process: audit; regular review of policy; participation of young people and 
parent in evaluation and future development of the service 
 Where possible, linking families to share information and experiences 
Regarding the medical documentation and administrative transfer an electronic patient file 
will be very helpful. Important information is then always available for every health care 
provider. Wherever possible, during the visits, the patient can also ask for the recall of the 
summary of the appointments as well as their blood test results, therefore creating an 
excellent knowledge of disease.  
Individualized transition plans (ITP) are important for a successful transfer to adult health 
care. Such plans need to incorporate items on the basic domain on organs and their function 
(pain, swelling, LOM), then activities of daily life (walking, sitting, standing, self hygiene) 
and participation in the society (walking to school, work, computer use, cooking, house-
cleaning, relations); (adapted from the international classification of functioning (73)). The 
young person has to be trained in knowledge and skills during transition. The skills and 
knowledge can be prepared by the pediatric and adult health department workers including 
the specialist, but may also include and important support from parents and peers (healthy 
as well with a chronic disease) (15).  
During the transition phase the ITP should be reviewed regularly by the transition 
coordinator. Omissions are easily identified and additional attention can be given to the 
patient.  
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And last but not least we need to include the patient’s opinion and learn to listen to them. 
This is not as obvious as it seems, as illustrated by the experience of describing disease 
activity of psoriasis. Where doctors measure numbers of plaques and percentage of affected 
skin area, our (adolescent) patients only care about skin lesions in their faces. From their 
viewpoint it can be stated that only if facial lesions regress, there is significant disease 
improvement. 
In order to create a substantial foundation based on factual data that results in a successful 
transfer in rheumatic diseases we need to define: 
What is the best parameter to measure a successful transfer:  
Would this be disease activity results, functional outcome or psychosocial parameters?  
Furthermore, we need to determine which test (pediatric or adult version) will be used to 
measure the parameter in adolescent age. 
When successful transfer is defined, research can be done to consider the right timing, for 
the individual patient, in a transition phase guided by both pediatric and adult carers with 
the inclusion of parents and peer support.  
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